Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004813

Chief Financial Officer sold 10,320 shares at an average $6.98 ($72,072)

  • Chief Financial Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PISKEL KYLE · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Grant or award : show line 1 in the form +125,000 279,330 D
2025-03-05 Sale : show line 2 in the form −3,103 $6.97 $21,628 276,227 D
2025-03-05 Sale : show line 3 in the form −253 $6.98 $1,766 275,974 D
2025-03-05 Sale : show line 4 in the form −6,964 $6.99 $48,678 269,010 D
Open-market sales · 10,320 sh · avg $6.98 · $72,072
Loading xslF345X05/form4.xml…